Third universal definition of myocardial infarction K Thygesen, JS Alpert, AS Jaffe, ML Simoons, BR Chaitman, HD White circulation 126 (16), 2020-2035, 2012 | 18900* | 2012 |
Reduced rate of hospital admissions for ACS during Covid-19 outbreak in Northern Italy O De Filippo, F D’Ascenzo, F Angelini, PP Bocchino, F Conrotto, ... New England Journal of Medicine 383 (1), 88-89, 2020 | 1129 | 2020 |
It’s time for a change to a troponin standard AS Jaffe, J Ravkilde, R Roberts, U Naslund, FS Apple, M Galvani, H Katus Circulation 102 (11), 1216-1220, 2000 | 1035 | 2000 |
How to use high-sensitivity cardiac troponins in acute cardiac care K Thygesen, J Mair, E Giannitsis, C Mueller, B Lindahl, S Blankenberg, ... European heart journal 33 (18), 2252-2257, 2012 | 1028 | 2012 |
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ... The Lancet 391 (10117), 219-229, 2018 | 930 | 2018 |
Recommendations for the use of cardiac troponin measurement in acute cardiac care K Thygesen, J Mair, H Katus, M Plebani, P Venge, P Collinson, B Lindahl, ... European heart journal 31 (18), 2197-2204, 2010 | 897 | 2010 |
Prodromal angina limits infarct size: a role for ischemic preconditioning F Ottani, M Galvani, D Ferrini, F Sorbello, P Limonetti, D Pantoli, ... Circulation 91 (2), 291-297, 1995 | 623 | 1995 |
Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina M Galvani, F Ottani, D Ferrini, JH Ladenson, A Destro, D Baccos, ... Circulation 95 (8), 2053-2059, 1997 | 532 | 1997 |
Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes F Ottani, M Galvani, FA Nicolini, D Ferrini, A Pozzati, G Di Pasquale, ... American heart journal 140 (6), 917-927, 2000 | 405 | 2000 |
Writing group on the joint ESC K Thygesen, JS Alpert, AS Jaffe, ML Simoons, BR Chaitman, HD White, ... ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial …, 2012 | 402 | 2012 |
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial SJ Connolly, JW Eikelboom, J Bosch, G Dagenais, L Dyal, F Lanas, ... The Lancet 391 (10117), 205-218, 2018 | 400 | 2018 |
Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on … K Thygesen, J Mair, C Mueller, K Huber, M Weber, M Plebani, Y Hasin, ... European heart journal 33 (16), 2001-2006, 2012 | 375 | 2012 |
Prothrombotic genetic risk factors in young survivors of myocardial infarction D Ardissino, PM Mannucci, PA Merlini, F Duca, R Fetiveau, L Tagliabue, ... Blood, The Journal of the American Society of Hematology 94 (1), 46-51, 1999 | 345 | 1999 |
A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes GUSTO IIb Investigators N Engl J Med 335, 775-782, 1996 | 302 | 1996 |
N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes M Galvani, F Ottani, L Oltrona, D Ardissino, GF Gensini, AP Maggioni, ... Circulation 110 (2), 128-134, 2004 | 267 | 2004 |
Natriuretic peptides for risk stratification of patients with acute coronary syndromes M Galvani, D Ferrini, F Ottani European journal of heart failure 6 (3), 327-333, 2004 | 266 | 2004 |
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019 | 249 | 2019 |
Alirocumab reduces total nonfatal cardiovascular and fatal events: the ODYSSEY OUTCOMES trial M Szarek, HD White, GG Schwartz, M Alings, DL Bhatt, VA Bittner, ... Journal of the American College of Cardiology 73 (4), 387-396, 2019 | 190 | 2019 |
Coagulation activation and long-term outcome in acute coronary syndromes D Ardissino, PA Merlini, KA Bauer, M Galvani, F Ottani, F Franchi, ... Blood 102 (8), 2731-2735, 2003 | 136 | 2003 |
Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: an insight into the mechanisms of cardiac involvement M Bertini, R Ferrari, G Guardigli, M Malagù, F Vitali, O Zucchetti, ... EP Europace 22 (12), 1848-1854, 2020 | 108 | 2020 |